Skip to main content
PolicySpeak
← All files
ANH

Asociación Hipofam

NGO · Spain

not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.

2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track Asociación in PolicySpeak: request access →

Work at Asociación Hipofam? so we know who speaks for it.

Follow the files Asociación Hipofam engages with

One email on Tuesdays when a new position is filed on these 2 files, from Asociación Hipofam or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Asociación Hipofam filed 2 positions between 26 Dec 2020 and 12 Nov 2025, across 2 of the 583 legislative files tracked here.

2020 · 1 filed2025 · 1 filed

What they argued

Revision of the EU legislation on medicines for children and rare diseasesfiled 26 Dec 2020source

Since Hipofam, we welcome the proposed changes and the willingness to improve access to and development of medicines for paediatric patients, and thus how improvements to the system of incentives for medicines for rare diseases. Although inclusion and reimbursement fall within the competence of the States, measures to improve fairness in access across the EU should be considered.

Filed in Spanish · English published by the European Commission

EU’s next long-term budget (MFF) – performance of the EU budgetfiled 12 Nov 2025source

1Health as an EU priority The best way to safeguard public health is through a dedicated health programme at European level, with protected funding and building on the achievements of the EU4Health programme. 2. Integrating health and rare diseases into the ECF The European Competitiveness Fund (ECF) should explicitly include and adequately support public health and rare disease actions.

Filed in Spanish · English published by the European Commission

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Asociación Hipofam next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Is this your organization?

Everything on this page comes from Asociación Hipofam’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.